Dr. Anurag Mairal

Director, Global Outreach Programs Stanford Byers Center for Biodesign, Stanford University

Dr. Anurag Mairal is the Director of Global Outreach Programs at the Stanford Byers Center for Biodesign, where he leads international initiatives focused on advancing healthcare innovation, medtech entrepreneurship, and design-driven problem solving. With deep expertise at the intersection of medicine, engineering, and global health, he plays a pivotal role in expanding the Biodesign innovation methodology to institutions, clinicians, and innovators worldwide.

At Stanford Biodesign, Dr. Mairal works closely with global academic partners, healthcare systems, startups, and policymakers to build sustainable innovation ecosystems. His work emphasizes translating unmet clinical needs into scalable solutions, particularly in resource-constrained and emerging-market settings. Through education, mentorship, and program development, he helps nurture the next generation of healthcare innovators.

Dr. Mairal is widely respected for his leadership in global health innovation, capacity building, and technology translation, enabling cross-border collaboration that accelerates impactful medical technologies from concept to clinical adoption.

Major Achievements

  • Director of Global Outreach Programs, Stanford Byers Center for Biodesign
  • Expanded Stanford Biodesign programs internationally, supporting healthcare innovation ecosystems across multiple countries.
  • Key contributor to the global adoption of the Biodesign innovation process, now used by universities, hospitals, and startups worldwide.
  • Mentor and advisor to clinicians, engineers, entrepreneurs, and medtech startups.
  • Leader in capacity building for healthcare innovation in emerging and developing regions.
  • Contributor to initiatives advancing affordable, scalable medical technologies.

Key Expertise & Talking Points

  • Healthcare innovation and medtech entrepreneurship
  • Stanford Biodesign methodology: need identification to implementation
  • Global health innovation and capacity building
  • Translational medicine and technology commercialization
  • Building innovation ecosystems across academia, industry, and healthcare
  • Designing scalable solutions for resource-limited settings
  • Leadership and education in biomedical innovation